Illuminating the
right decisions
for your patients

Illuminating the
right decisions
for your patients

Our technology illuminates medical diagnosis with a single draw of blood. Driving this advancement is our proprietary technology and AI-powered clinical analytics, AmpliMARK™. Compared to conventional approaches, we are able to support cancer diagnosis in a faster, cheaper, and simpler way. Our genomic tests enable physicians to make more informed clinical decisions - with the singular goal of improving patients' lives.

Genomic Medicine.
A new horizon of hope.

Our portfolio of genomic tests covers cancer
screening and tumor treatment, enabling better patient care.

Cancer Tests for Better Treatment
and Management of Patients

See our full range of diagnostic services.

Early Detection

Most cancers are currently detected in the late stages, which are associated with poor treatment outcomes and higher mortality rates. Early detection of cancer improves cancer survival rates and chances of cure. Our blood test can detect nasopharyngeal or nose cancer in its early stages before symptoms show.


Early cancer detection test for nasopharyngeal cancer

Learn more

Genetic Testing

Cancer is caused by changes in our DNA which are called mutations. Some of these mutations can be passed from one generation to another, causing hereditary cancers. Even though having these mutations does not mean one will get cancer, it increases the lifetime chances of one developing cancer. Genetic testing can help determine a person’s risk for developing cancer in their lifetime in order.


A multi-cancer blood test that detects gene mutations associated with cancer risk

Learn more


Focused subpanels that detect gene mutations associated with risk in specific cancer typese

Learn more

Treatment Selection and Monitoring

In recent years, the treatment of cancer has shifted from a one-size-fits-all approach using chemotherapy (which kills all cells including healthy cells) to targeted therapy (which kills only cancer cells and have fewer side effects). Based on clinical studies, patients with certain genetic mutations in their tumors have been shown to respond better to specific targeted drugs. Our diagnostic tests identify clinically-relevant genetic mutations in each tumor to find the right drug for the patient. Our tests can also help to monitor treatment response and signs of cancer recurrence.


Our flagship blood test that covers a wide range of clinically-relevant companion biomarkers

Learn more


In-depth genomic profiling of the patient’s haematological malignancy that covers a range of myeloid and lymphoid neoplasms.

Learn more


A comprehensive genomic profiling test that detects clinically-relevant genomic alterations in more than 500 genes.

Learn more


A companion diagnostic test that detects mutations in HRD genes.

Learn more

Workflow for Ordering a Lucence Test

Physician submits patient blood sample to Lucence

Lucence performs laboratory testing and generate test report with clinical interpretation

Lucence delivers test report to physician within the promised turnaround time

To order our tests, please call or email us. Our customer care team will assist you on the ordering process.


How can genomic testing help my patients?

Genomic testing is used to identify genetic mutations in the tumor to improve treatment selections for your patients. The presence or absence of certain mutations can predict who may benefit from certain drugs and who is not likely to respond. This helps to match your patients to the right treatment. We also have a test for early detection of nasopharyngeal cancer to enable earlier treatment. Our tests can also check whether a person is predisposed to cancer by detecting genes commonly associated with increased risk of cancer.

What is the accuracy rate of your tests?

All our diagnostic tests are clinically validated for accuracy and performed in our ISO 15189 accredited molecular diagnostics laboratory. Lucence also participates in external quality assessments to ensure that our tests meet industry benchmarks. We have achieved top-tier performance for our tests by international external quality assessment organizations such as the Quality Control for Molecular Diagnostics, and the European Molecular Genetics Quality Network .

What is the test turnaround time?

This depends on the type of test ordered which can range from one day to 21 days. Please check the test pages for details.

What technology is used in your tests?

Our tests are based on proprietary technology, which detects genomic alterations in tumor with higher sensitivity and accuracy than comparable approaches.

What countries are your tests available in?

Our tests are currently available across ASEAN and Hong Kong. Please contact our customer care team for further enquiries.

Need Help?